Atlas Trials

Canakinumab MAP in COVID-19 Pneumonia With CRS

Clinical trial NCT04476706 · NO_LONGER_AVAILABLE

Trial details

NCT number
NCT04476706
Sponsor
Novartis Pharmaceuticals
Status
NO_LONGER_AVAILABLE
Study type
EXPANDED_ACCESS
Cytokine Release Syndrome in COVID-19-induced Pneumonia

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.